Fate Therapeutics, Inc.
USD2.78
+0.05 (+1.83%)
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.65
Prev. Close
$2.73
Day Low
$2.60
Day High
$2.94
52W Low
$0.91
52W High
$3.23
Market Cap
$0.32B
Volume
1.69M
| 87,900 |
| $2.06 |
| 15 Jun 2026 | Xu Yuan | director | A-Award | Acquired | 87,900 | $2.06 |
| 15 Jun 2026 | Jooss Karin | director | A-Award | Acquired | 87,900 | $2.06 |
| 15 Jun 2026 | EPSTEIN ROBERT S | director | A-Award | Acquired | 87,900 | $2.06 |
| 15 Jun 2026 | Agarwal Shefali | director | A-Award | Acquired | 87,900 | $2.06 |
| 15 Jun 2026 | ABERNETHY MATT | director | A-Award | Acquired | 87,900 | $2.06 |
| 15 Jun 2026 | RASTETTER WILLIAM H | director | A-Award | Acquired | 87,900 | $2.06 |
| 15 Jun 2026 | Hamill Laura | director | A-Award | Acquired | 175,800 | $2.06 |
| 15 Jun 2026 | Hamill Laura | — | Disposed | 0 | $0.00 |